The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(((4-Benzyl-5-isobutyl-4H-1,2,4-triazol-3-yl)thio)methyl)benzamide ID: ALA4540941
PubChem CID: 155550627
Max Phase: Preclinical
Molecular Formula: C21H24N4OS
Molecular Weight: 380.52
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)Cc1nnc(SCc2ccc(C(N)=O)cc2)n1Cc1ccccc1
Standard InChI: InChI=1S/C21H24N4OS/c1-15(2)12-19-23-24-21(25(19)13-16-6-4-3-5-7-16)27-14-17-8-10-18(11-9-17)20(22)26/h3-11,15H,12-14H2,1-2H3,(H2,22,26)
Standard InChI Key: XAVWJHBFTVIFEL-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
23.5547 -3.4291 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.2292 -2.9670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9982 -2.1827 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.1808 -2.1601 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9069 -2.9304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1230 -3.1613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5311 -2.5979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7472 -2.8289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7230 -1.8036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5349 -4.2444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8175 -4.6357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1222 -4.2057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4053 -4.5963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3849 -5.4141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0875 -5.8397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8016 -5.4467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9991 -3.2410 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
25.6213 -2.7112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3912 -2.9851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5345 -3.7896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3036 -4.0636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9267 -3.5336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7757 -2.7262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0067 -2.4559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6970 -3.8065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8458 -4.6100 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.3185 -3.2759 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
7 9 1 0
1 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
2 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
22 25 1 0
25 26 2 0
25 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 380.52Molecular Weight (Monoisotopic): 380.1671AlogP: 3.92#Rotatable Bonds: 8Polar Surface Area: 73.80Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.09CX LogP: 4.18CX LogD: 4.18Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.60Np Likeness Score: -1.82
References 1. Chen D, Chen Y, Lian F, Chen L, Li Y, Cao D, Wang X, Chen L, Li J, Meng T, Huang M, Geng M, Shen J, Zhang N, Xiong B.. (2019) Fragment-based drug discovery of triazole inhibitors to block PDEδ-RAS protein-protein interaction., 163 [PMID:30562696 ] [10.1016/j.ejmech.2018.12.018 ]